abstract |
This refers to derivatives of hexafluorisopropanol substituted ether of the formula (1), in which R1 to R3 have the meanings defined in the description or in the claims, as well as to the physiologically acceptable salts and esters thereof. These compounds are fixed on LXR-alpha and LXR-beta and can be used as medicines. |